hires
AGTC Continues to Expand Management Team With Three Key Hires
GAINESVILLE, Fla., Oct. 5, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical-stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced the appointment of three new employees. Among these hires, Jonathan M. Sparks, Ph.D. will join AGTC as Vice President of Legal Affairs. The Company also announced the appointments...